Skip to main content
Home / The International Journal of Tuberculosis and Lung Disease, Volume 17, Number 8

Bronchial anthracofibrosis: treatment using airway stents [Case study]

Buy Article:

$34.78 + tax (Refund Policy)

Bronchial anthracofibrosis is a rare disease characterised by chronic bronchial inflammation, with bronchoscopic findings showing dark anthracotic pigmentation on the bronchial mucosa in conjunction with bronchial narrowing or obliteration which causes stenosis of the airways. We describe our experience in two patients with severe bronchial anthracofibrosis and discuss a novel treatment of the stenotic bronchi using endobronchial stents.

Keywords: anthracosis; bronchial stenosis; fibrosis; stent

Document Type: Research Article

Affiliations: Pulmonary Institute, Rabin Medical Center, Beilinson Campus, Petach Tikva; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

Publication date: 01 August 2013

More about this publication?

  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content